Annals of Nuclear Medicine

Papers
(The H4-Index of Annals of Nuclear Medicine is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Assessing dedicated breast PET performance in breast cancer screening alongside digital mammography, digital breast tomosynthesis, and ultrasound: a reader's insight116
Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer78
Conversion from dose length product to effective dose for the CT component of whole-body PET/CT46
Coronary plaque instability assessed by positron emission tomography and optical coherence tomography41
Optimization of injection dose in 18F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan38
Correction: Novel indices representing heterogeneous distributions of myocardial perfusion imaging29
18F-FET PET/CT can aid in diagnosing patients with indeterminate MRI findings for brain tumors: a prospective study28
A first-in-man study of [18F] FEDAC: a novel PET tracer for the 18-kDa translocator protein28
[18F]FDG PET/CT is useful in discriminating invasive adenocarcinomas among pure ground-glass nodules: comparison with CT findings—a bicenter retrospective study27
Highly specific amyloid and tau PET ligands for ATN classification in suspected Alzheimer’s disease patients26
FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?25
Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis20
Measuring myocardial blood flow with 82rubidium using Gjedde–Patlak–Rutland graphical analysis20
Comparison of the diagnostic accuracy of VSBONE BSI versions for detecting bone metastases in breast and prostate carcinoma patients using conventional and CZT detector gamma cameras19
Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose–positron emission tomography to differentiate between benign and malignant lesions19
The value of 18F-FDG PET/CT in Langerhans cell histiocytosis18
Efficacy of [68Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis16
Impact of irregular waveforms on data-driven respiratory gated PET/CT images processed using MotionFree algorithm16
0.052253007888794